What is the 13F Pro Quality Score for MLSS?

13F Pro ranks MILESTONE SCIENTIFIC INC. (MLSS) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View MLSS's current score at https://13fpro.ai/company/MLSS (free sign-up required for the full ranking).

Where does 13F Pro source MLSS data?

All MILESTONE SCIENTIFIC INC. fundamentals and ownership data come directly from SEC EDGAR. MILESTONE SCIENTIFIC INC. files with the SEC under CIK 855683. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is MLSS in?

MILESTONE SCIENTIFIC INC. (MLSS) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is MLSS research updated on 13F Pro?

MLSS's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

MILESTONE SCIENTIFIC INC.(MLSS)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →NYSEsmall

Institutional-grade research for retail investors

SEC EDGAR: CIK 855683 MLSS stock profile & AI dashboard →

13F Pro Quality Score

27.0/100

Rank #2,594 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why MLSS Scores 27/100

exact factor attribution · 2026-09-11

MLSS's composite is driven by earnings growth, held back by scale and profitability. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Earnings growth

+1.4 pts

79th pct

Earnings quality

+0.5 pts

55th pct

Institutional flow

-1.0 pts

31th pct

Shareholder dilution

-1.5 pts

20th pct

Revenue growth

-3.5 pts

33th pct

Free cash flow

-3.8 pts

25th pct

Capital efficiency

-4.1 pts

9th pct

Profitability

-4.7 pts

19th pct

Scale

-6.4 pts

7th pct

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

MLSS Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for MILESTONE SCIENTIFIC INC. (MLSS), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores MLSS at 27.0/100 on a 32-signal composite quality model, placing it at rank #2,594 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), MILESTONE SCIENTIFIC INC. reports quarterly revenue of $2.8M, net income of $-1.1M, an operating margin of -37.4%. Top institutional holders of MLSS by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, Stonepine Capital Management, GEODE CAPITAL MANAGEMENT, based on the most recent SEC filings. MLSS trades on the NYSE exchange and files with the SEC under CIK 855683. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MLSS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MILESTONE SCIENTIFIC INC. directly from SEC EDGAR. MILESTONE SCIENTIFIC INC.'s 13F Pro composite quality score has ranged between 19 and 50 since 2026, currently 27.0 — an improving long-term trajectory across 8 quarterly and live scoring snapshots.

✦

Fun facts about MILESTONE SCIENTIFIC INC.

Quirks, history, and lore behind MLSS — the kind of stuff that makes a stock memorable.

1
The Basics
A small-cap medical device company · listed on NYSE American · headquartered in New Jersey · focused on drug and fluid delivery technology.
2
The Numbers
Annual revenue in the range of tens of millions of dollars — firmly micro-cap territory — with a business model that blends device sales with disposable consumables.
3
The History
Founded in the 1989–1991 era, the company spent decades commercializing a proprietary computer-controlled injection system aimed at making needle sticks far less painful.
4
The Secret
Its core technology uses a pressure-sensing algorithm to detect when a needle tip is in the correct tissue — a technique it calls CompuFlo — reducing the guesswork of traditional injections.
5
The Lore
The company's flagship dental device was branded The Wand — because who wants a scary syringe when you can have something that sounds like magic?
6
The Giveaway
Its ticker is MLSS, its name evokes scientific achievement, and its CompuFlo platform has expanded from pain-free dentistry into epidural and joint injection applications.

▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q2 2026

$2.8M

Net Income

Q2 2026

$-1.1M

Free Cash Flow

Q2 2026

$-589.3K

Operating Margin

Q2 2026

-37.4%

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+4.0% YoY

$9.0MFY 2025

FY22 $8.8MFY23 $9.8MFY24 $8.6MFY25 $9.0M

Net Income

-21.4% YoY

$-5.7MFY 2025

FY22 $-8.7MFY23 $-6.9MFY24 $-4.7MFY25 $-5.7M

Operating Income

+15.7% YoY

$-5.7MFY 2025

FY22 $-8.8MFY23 $-7.1MFY24 $-6.8MFY25 $-5.7M

EPS (Diluted)

-16.7% YoY

$-0.07FY 2025

FY22 —FY23 —FY24 $-0.06FY25 $-0.07

Total Assets

-20.3% YoY

$7.8MFY 2025

FY22 $13.7MFY23 $11.4MFY24 $9.8MFY25 $7.8M

Op. Cash Flow

+0.1% YoY

$-2.9MFY 2025

FY22 $-6.0MFY23 $-5.3MFY24 $-2.9MFY25 $-2.9M

Free Cash Flow

-0.1% YoY

$-2.9MFY 2025

FY22 $-6.0MFY23 —FY24 $-2.9MFY25 $-2.9M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$9.0M +4.0%	$8.6M -12.2%	$9.8M +11.6%	$8.8M -14.5%	$10.3M +89.5%	$5.4M
Net Income	$-5.7M -21.4%	$-4.7M +32.0%	$-6.9M +20.4%	$-8.7M -27.7%	$-6.8M +7.1%	$-7.3M
Operating Income	$-5.7M +15.7%	$-6.8M +4.9%	$-7.1M +19.5%	$-8.8M -19.6%	$-7.4M +1.0%	$-7.5M
EPS (Diluted)	$-0.07 -16.7%	$-0.06	—	—	$-0.10 +16.7%	$-0.12
Total Assets	$7.8M -20.3%	$9.8M -13.8%	$11.4M -17.0%	$13.7M -30.8%	$19.8M +1.2%	$19.6M
Operating Cash Flow	$-2.9M +0.1%	$-2.9M +45.2%	$-5.3M +11.7%	$-6.0M -49.5%	$-4.0M +42.3%	$-7.0M
Free Cash Flow	$-2.9M -0.1%	$-2.9M	—	$-6.0M -49.2%	$-4.0M +42.2%	$-7.0M

Get alerted when MLSS's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for MILESTONE SCIENTIFIC INC. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of MLSS

VANGUARD CAPITAL MANAGEMENT LLC
$665.5K2,073,166 sh
Stonepine Capital Management, LLC
$348.6K666,666 sh
GEODE CAPITAL MANAGEMENT, LLC
$206.7K643,611 sh
VANGUARD FIDUCIARY TRUST CO
$149.1K464,449 sh
STATE STREET CORP
$85.0K264,885 sh
Newbridge Financial Services Group, Inc.
$45.3K141,000 sh
NORTHERN TRUST CORP
$42.7K133,067 sh
LPL Financial LLC
$40.1K124,945 sh
Mariner, LLC
$39.1K121,750 sh
Carnegie Investment Counsel
$32.2K100,175 sh

Fund	Value	Shares
VANGUARD CAPITAL MANAGEMENT LLC	$665.5K	2,073,166
Stonepine Capital Management, LLC	$348.6K	666,666
GEODE CAPITAL MANAGEMENT, LLC	$206.7K	643,611
VANGUARD FIDUCIARY TRUST CO	$149.1K	464,449
STATE STREET CORP	$85.0K	264,885
Newbridge Financial Services Group, Inc.	$45.3K	141,000
NORTHERN TRUST CORP	$42.7K	133,067
LPL Financial LLC	$40.1K	124,945
Mariner, LLC	$39.1K	121,750
Carnegie Investment Counsel	$32.2K	100,175

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put MLSS on your watchlist

Track score changes the day MILESTONE SCIENTIFIC INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is MLSS a good stock to buy?

13F Pro's AI-powered analysis of MILESTONE SCIENTIFIC INC. (MLSS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for MLSS are available on the MLSS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. MLSS is classified as a small company.

Which hedge funds own MLSS?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling MLSS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of MILESTONE SCIENTIFIC INC.'s investment landscape.